After a night’s sleep and a couple hundred angry comments and emails, I think I’ve figured a couple of things out about the Ryan Braun reaction and people’s overall feelings about MLB’s drug testing program. Mostly, though, I’m just dumbfounded at the cynicism and intellectual dishonesty of so many who wish to ignore the arbitrator’s ruling and cast Braun as a PED-using villain regardless.
For years, people argued for Major League Baseball to adopt a rigorous testing regime. Why? To end the speculation. To stop the “is he using or isn’t he” parlor games. Read every single column written about Jeff Bagwell’s Hall of Fame candidacy and you’ll find some variation of “but for so long there was no testing, so we just can’t know, and that uncertainty is horrible …” sentiment.
Now we have a testing program. And it’s amazing to me just how quickly the end product of that testing program — no suspension for Ryan Braun — is diminished or outright dismissed when results aren’t what people wanted.
I’m talking about those who don’t care that the procedures weren’t followed and say that they still don’t think Braun is clean, his name not cleared. Sure, you’re allowed to think that if you want, but just understand that if you do — if “we still don’t think he’s clean” or “questions still remain” holds — then there is no purpose whatsoever to have a testing program in the first place. Because even with one in place, people will just assume what they want to assume regardless of the end product, and that’s no different than where we were in 1998.
The reason? Because no scientific protocol has legitimacy if only some parts of it are adhered to and others aren’t. When you go with testing, you go with everything. You can’t say that the preliminary test results matter and the chain of custody protocols don’t. It’s all of a piece. It’s the entire process that lends drug testing its legitimacy, not just part of it.
But hey, if you still want to crap on Braun — if you still want to say “but his testosterone levels were high, so he’s suspect” or “MLB has egg on its face because the testing failed” — fine. Do so. It’s a free country. But if you do so, admit that you do it because you simply don’t like the results here. And spare me any whining about the past, and about how Major League Baseball was so lax in testing for so many years before now. Because as is evidenced by your Ryan Braun reactions, you wouldn’t have cared regardless.
MASN’s Roch Kubatko is reporting that the Orioles have “some level” of interest in free agent outfielder Denard Span. The Nationals did not make a $15.8 million qualifying offer to Span, which means he doesn’t come attached with draft pick compensation unlike other free agents such as Alex Gordon and Dexter Fowler.
Span, who turns 32 in February, hit a solid .301/.365/.431 with five home runs, 22 RBI, 38 runs scored, and 11 stolen bases, but took only 275 plate appearances due to back and hip injuries. He underwent season-ending hip surgery in September but is expected to be ready to participate in spring training.
The Mets and Royals have also reportedly shown interest in Span’s services.
ESPN’s Jerry Crasnick reports that the Blue Jays are on the prowl for relievers with closing experience. Ryan Madson is one of the names on their list.
Madson, 35, had a career rebirth with the Royals in 2015. He signed a minor league deal with the club that paid him a salary of $850,000 if he made it back to the majors. Due to a plethora of arm injuries, Madson hadn’t pitched in the majors since Game 5 of the 2011 NLDS against the Cardinals as a member of the Phillies. For the Royals, he wound up becoming a crucial member of the bullpen, finishing with a 2.13 ERA and a 58/14 K/BB ratio over 63 1/3 innings.
While Madson allowed five runs in 8 1/3 post-season innings, he pitched well when it mattered most, as he hurled three scoreless frames in three appearances in the World Series against the Mets.
Madson has closing experience, with 55 career saves. 32 of them came in 2011 when he took over the closer’s role from Brad Lidge.
After signing Marco Estrada and J.A. Happ, and trading for Jesse Chavez, the Jays have bolstered their rotation but it was reported on Saturday that interim GM Tony LaCava is still focused on upgrading the pitching staff.
ESPN’s Buster Olney reports that free agent pitcher Trevor Cahill is looking for a one-year, bounce-back deal. The Pirates are one of the potential teams he is considering.
It’s no surprise that the Pirates are on Cahill’s list. Pirates pitching coach Ray Searage has garnered a reputation as a miracle worker after turning around the careers of a handful of pitchers, including Edinson Volquez, Francisco Liriano, and J.A. Happ. Volquez parlayed a one-year, $5 million deal with the Pirates into a two-year, $20 million deal with the Royals last December. Liriano signed with the Pirates on a one-year, $1 million contract and turned that into a three-year, $39 million deal. Happ, dealt to the Pirates from the Mariners at the most recent trade deadline, just signed a three-year, $39 million contract with the Blue Jays.
Cahill, once a highly-regarded pitching prospect, has scuffled over parts of seven seasons in the majors. The 27-year-old owns a career 4.13 ERA with a 754/427 K/BB ratio in 1,083 2/3 innings. Cahill had some brief success after signing with the Cubs as a free agent in mid-August, compiling a 2.12 ERA in 11 appearances out of the bullpen.
Jon Heyman of CBS Sports reports that the Blue Jays have narrowed their search for a new general manager down to two candidates: current interim GM Tony LaCava, and Indians vice president of player personnel Ross Atkins. Former Jays GM Alex Anthopoulos resigned last month.
LaCava was promoted to interim GM on November 2 and has already made a handful of moves along with new president Mark Shapiro. The club acquired Jesse Chavez in a trade and signed pitchers Marco Estrada and J.A. Happ to multi-year deals.
Atkins worked under Shapiro in the Indians organization for 15 seasons, so it is no surprise that he is a finalist for the open GM position.